Status:
COMPLETED
Antiglutamate Anticonvulsants in the Treatment of Alcohol Withdrawal Syndrome
Lead Sponsor:
St. Petersburg State Pavlov Medical University
Conditions:
Topiramate
Lamotrigine
Eligibility:
All Genders
20-60 years
Phase:
NA
Brief Summary
The study is aimed to evaluate the efficacy of antiglutamate anticonvulsants (topiramate, lamotrigine, and memantine) in the treatment of alcohol withdrawal syndrome
Eligibility Criteria
Inclusion
- Alcohol dependence Alcohol withdrawal syndrome
Exclusion
- Drug dependence Major psychiatric diagnoses Severe somatic illness
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00241995
Last Update
October 18 2006
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.